XOMA (XOMA) News Today → Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad) Free XOMA Stock Alerts $25.41 +0.05 (+0.20%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineXOMA (NASDAQ:XOMA) Rating Reiterated by HC Wainwrightamericanbankingnews.com - April 27 at 3:18 AMXOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)finance.yahoo.com - April 25 at 8:40 AMXOMA's (XOMA) Buy Rating Reiterated at HC Wainwrightmarketbeat.com - April 25 at 8:09 AMXOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One's OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)globenewswire.com - April 25 at 7:30 AMXOMA (NASDAQ:XOMA) Share Price Crosses Above 200-Day Moving Average of $20.30americanbankingnews.com - April 25 at 3:14 AMActym Therapeutics Appoints Thomas Smart as CEOprnewswire.com - April 24 at 9:00 AMXOMA (NASDAQ:XOMA) shareholders have earned a 16% CAGR over the last five yearsfinance.yahoo.com - April 20 at 9:43 AMXOMA Co. (NASDAQ:XOMA) Shares Sold by Stonepine Capital Management LLCmarketbeat.com - April 9 at 9:43 PMXOMA Corporation Announces Closing of Tender Offerglobenewswire.com - April 3 at 9:00 AMXOMA Declares Quarterly Preferred Stock Dividendsglobenewswire.com - March 21 at 7:30 AMXOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.globenewswire.com - March 19 at 4:05 PMKINNATE BIOPHARMA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kinnate Biopharma Inc. - KNTEbusinesswire.com - March 13 at 11:49 AMXOMA Stock Earnings: XOMA Misses EPS, Misses Revenue for Q4 2023investorplace.com - March 8 at 1:03 PMXOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Valuefinance.yahoo.com - March 8 at 7:51 AMXOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Valueglobenewswire.com - March 8 at 7:30 AMXOMA to Present at Upcoming Investor Conferences in Marchglobenewswire.com - February 28 at 7:30 AMKINNATE BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kinnate Biopharma Inc. - KNTEbusinesswire.com - February 19 at 11:03 AMCompare with Maple Leaf Green World Inc (4HV0)msn.com - February 18 at 12:30 PMXOMA Mar 2024 20.000 putfinance.yahoo.com - February 17 at 10:21 AMXOMA Jun 2024 25.000 callfinance.yahoo.com - February 17 at 10:21 AMXOMA's (XOMA) "Buy" Rating Reiterated at HC Wainwrightmarketbeat.com - February 16 at 2:46 PMBiotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharmabenzinga.com - February 16 at 1:37 PMXOMA Agrees to Acquire Kinnate Biopharmamarketwatch.com - February 16 at 8:36 AMXOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Rightfinance.yahoo.com - February 16 at 8:36 AMXOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Rightfinance.yahoo.com - February 16 at 8:36 AMXOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Rightglobenewswire.com - February 16 at 8:00 AMmarketbeat.com - February 16 at 7:59 AMXOMA Co. (NASDAQ:XOMA) Short Interest Up 13.1% in Januarymarketbeat.com - February 14 at 4:19 AMXOMA (NASDAQ:XOMA) Shares Cross Above 200-Day Moving Average of $16.86marketbeat.com - February 8 at 4:24 AMWith 37% ownership, XOMA Corporation (NASDAQ:XOMA) has piqued the interest of institutional investorsfinance.yahoo.com - January 20 at 2:06 PMXOMA To Pay $1 Mln Milestone To LadRx As FDA Accepts Zevra's Arimoclomol NDA For NPCmarkets.businessinsider.com - January 11 at 10:48 PMFDA Acceptance of Zevra's Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRxtmcnet.com - January 11 at 5:46 PMXoma to Make $1M Milestone Payment to LadRx After FDA Accepts Zevra Application for Arimoclomolmarketwatch.com - January 11 at 5:46 PMXoma To Make $1 Mln Milestone Payment To LadRx After FDA Accepts Zevra's NDA For Arimoclomolmarkets.businessinsider.com - January 11 at 5:46 PMFDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRxfinance.yahoo.com - January 11 at 5:46 PMXoma appoints Owen Hughes as CEO, Jack Wyszomierski as chairmanseekingalpha.com - January 8 at 9:19 AMXOMA Corp. Dep. Pfd. (Rep. 8.375% Cum. Pfd. Series B)wsj.com - January 6 at 10:31 AMXOMA announces stock repurchase program of up to $50Mmsn.com - January 2 at 1:49 PMXOMA Sets Initial Stock Buyback of $50 Millionmarketwatch.com - January 2 at 8:49 AMXOMA To Repurchase Up To $50 Mln Of Sharesmarkets.businessinsider.com - January 2 at 8:49 AMXOMA Announces Stock Repurchase Program of up to $50 Millionfinance.yahoo.com - January 2 at 8:49 AMXOMA Preferreds: I Upped My Rating On One Preferred Stock To A Buyseekingalpha.com - December 29 at 7:04 AMXOMA Preferred Shares Series A declares $0.5391 dividendmsn.com - December 20 at 8:46 AMXOMA Corp - 8.625% PRF PERPETUAL USD 25 - Ser A (XOMAP) Price Target Increased by 16.29% to 107.75msn.com - November 27 at 9:44 PMXOMAP XOMA Corporation 8.625% CUM PFD Aseekingalpha.com - November 25 at 2:58 PMXOMA Corporation (0M26.L)uk.finance.yahoo.com - November 22 at 4:01 PMXOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder Valuefinance.yahoo.com - November 7 at 8:23 AMPositive Trajectory for Xoma: Buy Rating Supported by Promising Drug Developments and Increased Royalty Revenuemarkets.businessinsider.com - November 1 at 8:05 AMXOMA gets $5M milestone upon FDA's acceptance of Day One's Tovorafenib NDAmsn.com - October 31 at 10:08 AMXOMA Earns $5 Million Milestone Upon FDA Acceptance of Day One’s Tovorafenib NDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)finance.yahoo.com - October 31 at 10:08 AM Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here XOMA Media Mentions By Week XOMA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XOMA News Sentiment▼0.490.33▲Average Medical News Sentiment XOMA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XOMA Articles This Week▼71▲XOMA Articles Average Week Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Verastem News Vanda Pharmaceuticals News Rigel Pharmaceuticals News Regulus Therapeutics News Lexicon Pharmaceuticals News Syros Pharmaceuticals News Emergent BioSolutions News Cue Biopharma News OPKO Health News Innoviva News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XOMA) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyUrgent Nvidia WarningAltimetryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
